Hudson, JemmaCruickshank, MoiraQuinton, RichardAucott, LornaAceves Martins, MagalyGillies, KatieBhasin, ShalenderSnyder, PeterEllenberg, SusanGrossmann, MathisTravison, ThomasGianatti, Emilyvan der Schouw, YvonneEmmelot Vonk, MarielleGilaty, ErikHackett, GeoffRamchandran, SudarshanSvartberg, JohanHildreth, KerryGroti Antoniv, KristinaBrock, GeraldTenover, LisaMeng , HuiHo Chee Kong, ChristopherShen Tan, WeiMark, LeonardRoss, RichardSchwartz, RobertManson, PaulRoberts, StephenSkicsage Andersen, MarianneVelling, LineHernández, Rodolfo AndrésOliver, NickWu, Frederick C WDhillo, Waljit S.Bhattacharya, SiladityaBrazzelli, MiriamJayasena, Channa N2022-06-212022-06-212022-06Hudson, J, Cruickshank, M, Quinton, R, Aucott, L, Aceves Martins, M, Gillies, K, Bhasin, S, Snyder, P, Ellenberg, S, Grossmann, M, Travison, T, Gianatti, E, van der Schouw, Y, Emmelot Vonk, M, Gilaty, E, Hackett, G, Ramchandran, S, Svartberg, J, Hildreth, K, Groti Antoniv, K, Brock, G, Tenover, L, Meng , H, Ho Chee Kong, C, Shen Tan, W, Mark, L, Ross, R, Schwartz, R, Manson, P, Roberts, S, Skicsage Andersen, M, Velling, L, Hernández, R A, Oliver, N, Wu, F C W, Dhillo, W S, Bhattacharya, S, Brazzelli, M & Jayasena, C N 2022, 'Adverse cardiovascular events and mortality in men during testosterone treatment : an individual patient and aggregate data meta-analysis', The Lancet Healthy Longevity, vol. 3, no. 6, pp. e381–393. https://doi.org/10.1016/S2666-7568(22)00096-42666-7568ORCID: /0000-0001-7890-2854/work/114809151ORCID: /0000-0002-5182-884X/work/114809323ORCID: /0000-0002-9441-142X/work/114809501ORCID: /0000-0001-6277-7972/work/114809505ORCID: /0000-0002-7576-6751/work/115507487ORCID: /0000-0003-2619-8230/work/159078540https://hdl.handle.net/2164/18728Funding National Institute for Health Research Health Technology Assessment Programme. Acknowledgments This work was supported by the National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme (project no 17/68/01). The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR HTA Programme, or the Department of Health and Social Care, UK. The funders were not actively involved in the research process at any stage. The study design; collection, analysis, and interpretation of data; writing of the manuscript; and decision to submit for publication were performed independent of the funders. The Health Services Research Unit at the University of Aberdeen is funded by the Chief Scientist Office of the Scottish Government Health and Social Care Directorates. The Section of Endocrinology and Investigative Medicine at Imperial College London is funded by grants from the Medical Research Council, Biotechnology and Biological Sciences Research Council, NIHR, an Integrative Mammalian Biology Capacity Building Award, an FP7-HEALTH-2009-241592 EuroCHIP grant, and is supported by the NIHR Biomedical Research Centre Funding Scheme. The following authors are also funded as follows: NIHR Research Professorship (WSD), NIHR post-doctoral fellowship (CNJ). SBhasin receives National Institutes of Health research grant funding. The authors are grateful to Prakash Abraham, Alison Avenell, Craig Ramsay, Graham Scotland, Neil Scott, and Finlay MacKenzie for their advice; and to the many individuals from academia and industry who helped in the conduct of this study.14715563engSDG 3 - Good Health and Well-beingR MedicineNational Institute for Health Research (NIHR)RAdverse cardiovascular events and mortality in men during testosterone treatment : an individual patient and aggregate data meta-analysisJournal article10.1016/S2666-7568(22)00096-436